88 related articles for article (PubMed ID: 24446390)
1. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
[TBL] [Abstract][Full Text] [Related]
2. MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPER.
Boscaro C; Ramaschi GE; Trevisi L; Cignarella A; Bolego C
Life Sci; 2023 Nov; 333():122135. PubMed ID: 37778413
[TBL] [Abstract][Full Text] [Related]
3. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival.
Liu S; Le May C; Wong WP; Ward RD; Clegg DJ; Marcelli M; Korach KS; Mauvais-Jarvis F
Diabetes; 2009 Oct; 58(10):2292-302. PubMed ID: 19587358
[TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells.
Albanito L; Lappano R; Madeo A; Chimento A; Prossnitz ER; Cappello AR; Dolce V; Abonante S; Pezzi V; Maggiolini M
Environ Health Perspect; 2008 Dec; 116(12):1648-55. PubMed ID: 19079715
[TBL] [Abstract][Full Text] [Related]
5. Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation.
Molina L; Bustamante F; Ortloff A; Ramos I; Ehrenfeld P; Figueroa CD
Front Endocrinol (Lausanne); 2020; 11():563165. PubMed ID: 33117280
[TBL] [Abstract][Full Text] [Related]
6. The G-protein-coupled estrogen receptor GPER in health and disease.
Prossnitz ER; Barton M
Nat Rev Endocrinol; 2011 Aug; 7(12):715-26. PubMed ID: 21844907
[TBL] [Abstract][Full Text] [Related]
7. Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts.
Albanito L; Lappano R; Madeo A; Chimento A; Prossnitz ER; Cappello AR; Dolce V; Abonante S; Pezzi V; Maggiolini M
Environ Health Perspect; 2015 May; 123(5):493-9. PubMed ID: 25616260
[TBL] [Abstract][Full Text] [Related]
8. Evidence for G-Protein-Coupled Estrogen Receptor as a Pronatriuretic Factor.
Gohar EY; Daugherty EM; Aceves JO; Sedaka R; Obi IE; Allan JM; Soliman RH; Jin C; De Miguel C; Lindsey SH; Pollock JS; Pollock DM
J Am Heart Assoc; 2020 May; 9(10):e015110. PubMed ID: 32390531
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone-induced hypertension is sex-dependent, mediated by T cells and sensitive to GPER activation.
Dinh QN; Vinh A; Kim HA; Saini N; Broughton BRS; Chrissobolis S; Diep H; Judkins CP; Drummond GR; Sobey CG
Cardiovasc Res; 2021 Feb; 117(3):960-970. PubMed ID: 32215568
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.
Ström A; Hartman J; Foster JS; Kietz S; Wimalasena J; Gustafsson JA
Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1566-71. PubMed ID: 14745018
[TBL] [Abstract][Full Text] [Related]
11. In vivo potentiation of muscle torque is enhanced in female mice through estradiol-estrogen receptor signaling.
Le G; Baumann CW; Warren GL; Lowe DA
J Appl Physiol (1985); 2023 Mar; 134(3):722-730. PubMed ID: 36735234
[TBL] [Abstract][Full Text] [Related]
12. GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments.
Tirado-Garibay AC; Falcón-Ruiz EA; Ochoa-Zarzosa A; López-Meza JE
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834441
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of estrogen receptor subtypes in ovarian high-grade serous carcinoma and clear cell carcinoma.
Osaku D; Oishi T; Kawamura N; Iida Y; Komatsu H; Kudoh A; Chikumi J; Sato S; Harada T
Reprod Med Biol; 2021 Oct; 20(4):467-476. PubMed ID: 34646075
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the estrogen receptor profile of cardiovascular tissues during aging.
Gurrala R; Kilanowski-Doroh IM; Hutson DD; Ogola BO; Zimmerman MA; Katakam PVG; Satou R; Mostany R; Lindsey SH
Geroscience; 2021 Feb; 43(1):433-442. PubMed ID: 33558965
[TBL] [Abstract][Full Text] [Related]
15. Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer.
Zhang D; Chen H; Wang J; Ji J; Imam M; Zhang Z; Yan S
Front Cell Dev Biol; 2024; 12():1338448. PubMed ID: 38476263
[TBL] [Abstract][Full Text] [Related]
16. Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist.
Ding Q; Chorazyczewski J; Gros R; Motulsky HJ; Limbird LE; Feldman RD
Pharmacol Res Perspect; 2022 Oct; 10(5):e00995. PubMed ID: 36065843
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive understanding of the role of GPER in estrogen receptor-alpha negative breast cancer.
Abbas MA; Al-Kabariti AY; Sutton C
J Steroid Biochem Mol Biol; 2024 Apr; 241():106523. PubMed ID: 38636681
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory Anticancer Effect of Resveratrol Mediated by G Protein-Coupled Estrogen Receptor in Colorectal Cancer.
Kim N; Kwon J; Shin US; Jung J
Biomol Ther (Seoul); 2023 Nov; 31(6):655-660. PubMed ID: 37817377
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases.
Visniauskas B; Kilanowski-Doroh I; Ogola BO; Mcnally AB; Horton AC; Imulinde Sugi A; Lindsey SH
J Hum Hypertens; 2023 Aug; 37(8):609-618. PubMed ID: 36319856
[TBL] [Abstract][Full Text] [Related]
20. Exploring the physiological role of the G protein-coupled estrogen receptor (GPER) and its associations with human diseases.
Żabińska M; Wiśniewska K; Węgrzyn G; Pierzynowska K
Psychoneuroendocrinology; 2024 May; 166():107070. PubMed ID: 38733757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
